Manuel et al. proposed that for the same CRC patient, STn+ CTC counts were significantly higher than EpCAM+ CTCs counts, and they constructed a glycan affinity-based microfluidic device that improved the separation efficiency of CTCs in the peripheral blood of CRC and bladder cancer patients [36]. Here, EPCAM is linked to colorectal carcinoma.